Dexamethasone, a drug of the family of the steroids tested by the clinical trial british Recovery, is known for its powerful anti-inflammatory.
British researchers announced, Tuesday, June 16, after a “a major breakthrough” in the treatment of seriously ill patients by the Covid-19. The leaders of the clinical trial british Recovery (article in English) have discovered that a drug of the family of the steroid, dexamethasone, to reduce by one third the mortality in patients with the most severely affected, that is to say those requiring the assistance of a respirator. According to them, “a death on eight could be avoided through this treatment for patients placed under mechanical ventilation”.
The world health Organization (WHO) has welcomed a “scientific breakthrough”. “This is the first treatment proven to reduces the mortality in patients with by the Covid-19 under the assistance of oxygen or a respirator”said Tedros Adhanom Ghebreyesus, the director-general of WHO. This drug is already used in many indications for its anti-inflammatory effect powerful.
“The researchers have shared the first information about the results of the test with the WHO, and we sincerely hope to know the complete analysis of the data in the next few days”added the world health Organization. The organization un will conduct a “meta-analysis” of such research for the purpose of updating its guidelines for “reflect how and when the drug should be used” against the disease.
–
